IBP Stock Analysis: Installed Building Products | NYSE
Residential Construction | NYSE, USA | Market Cap: 5.929m USD | 12M Return: -9.8% | US45780R1014 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 84.3M
EPS Trend: -2.3%
Qual. Beats: 0
Rev. Trend: 88.1%
Qual. Beats: 2
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Installed Building Products, Inc. (IBP) is a U.S.-based specialty contractor focused primarily on installing insulation and a broad array of complementary building products for residential and commercial builders. Founded in 1977 and headquartered in Columbus, Ohio, the company has operated since its 2014 NYSE IPO and is classified within the Consumer Discretionary sector under the Homebuilding sub-industry.
The company operates through three reporting segments: Installation, Distribution, and Manufacturing Operations. Beyond its core insulation offerings-which span fiberglass, cellulose, and spray foam materials-IBP provides installation services for garage doors and openers, shower doors, mirrors, closet shelving, rain gutters, waterproofing, fire-stopping systems, and window coverings such as blinds and shades. This diversified product mix allows the business to capture multiple revenue streams within a single new build or remodel project.
IBP also distributes wholesale insulation products and related equipment to installers, integrating its operations vertically within the building products supply chain. By serving both new construction and repair/remodel markets across multiple U.S. regions, the companys revenue is tied to housing starts, renovation cycles, and commercial construction activity-making it sensitive to interest rates and broader macroeconomic conditions affecting the homebuilding sector.
- Housing starts decline pressures residential insulation installation demand
- Acquisition strategy expands market share and drives installation segment growth
- Labor and material cost inflation squeezes installation segment margins
| Net Income: 235.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 8.08 > 1.0 |
| NWC/Revenue: 27.11% < 20% (prev 22.30%; Δ 4.81% < -1%) |
| CFO/TA 0.14 > 3% & CFO 310.8m > Net Income 235.7m |
| Net Debt (907.9m) to EBITDA (498.1m): 1.82 < 3 |
| Current Ratio: 3.12 > 1.5 & < 3 |
| Outstanding Shares: last quarter (26.5m) vs 12m ago -2.45% < -2% |
| Gross Margin: 33.07% > 18% (prev 33.62%; Δ -0.55% > 0.5%) |
| Asset Turnover: 137.6% > 50% (prev 145.0%; Δ -7.37% > 0%) |
| Interest Coverage Ratio: 9.01 > 6 (EBIT TTM 354.8m / Interest Expense TTM 39.4m) |
| A: 0.35 (Total Current Assets 1.19b - Total Current Liabilities 382.7m) / Total Assets 2.30b |
| B: 0.49 (Retained Earnings 1.12b / Total Assets 2.30b) |
| C: 0.16 (EBIT TTM 354.8m / Avg Total Assets 2.18b) |
| D: 0.43 (Book Value of Equity 696.3m / Total Liabilities 1.60b) |
| Altman-Z'' = 5.46 = AAA |
| DSRI: 1.00 (Receivables 485.2m/482.7m, Revenue 2.99b/2.97b) |
| GMI: 1.02 (GM 33.62% / 33.07%) |
| AQI: 0.96 (AQ_t 0.34 / AQ_t-1 0.36) |
| SGI: 1.01 (Revenue 2.99b / 2.97b) |
| TATA: -0.03 (NI 235.7m - CFO 310.8m) / TA 2.30b) |
| Beneish M = -3.03 (Cap -4..+1) = AA |
As of November 16, 2026, the stock is trading at USD 229.00 with a total of 934,007 shares traded. Over the past week, the price has changed by +4.06%, over one month by +21.64%, over three months by -6.76% and over the past year by -9.75%.
Current recommended Stop Loss: 216.20 (which is 5.6% or 1.2 ATR below the current price).
Installed Building Products has received a consensus analysts rating of 3.40. Therefore, it is recommended to hold IBP.
- StrongBuy: 3
- Buy: 0
- Hold: 12
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 212.9 | -7% |
P/E Trailing = 25.4077
P/E Forward = 19.5695
P/S = 2.0004
P/B = 8.8304
P/EG = 1.2
Revenue TTM = 2.99b USD
EBIT TTM = 354.8m USD
EBITDA TTM = 498.1m USD
Long Term Debt = 850.0m USD (from longTermDebt, last fiscal year)
Short Term Debt = 77.4m USD (from shortTermDebt, last quarter)
Debt = 1.32b USD (from shortLongTermDebtTotal, last quarter) + Leases 135.0m
Net Debt = 907.9m USD (calculated: Debt 1.32b - CCE 415.9m)
Enterprise Value = 6.84b USD (5.93b + Debt 1.32b - CCE 415.9m)
Interest Coverage Ratio = 9.01 (Ebit TTM 354.8m / Interest Expense TTM 39.4m)
EV/FCF = 27.88x (Enterprise Value 6.84b / FCF TTM 245.2m)
FCF Yield = 3.59% (FCF TTM 245.2m / Enterprise Value 6.84b)
FCF Margin = 8.19% (FCF TTM 245.2m / Revenue TTM 2.99b)
Net Margin = 7.87% (Net Income TTM 235.7m / Revenue TTM 2.99b)
Gross Margin = 33.07% ((Revenue TTM 2.99b - Cost of Revenue TTM 2.00b) / Revenue TTM)
Gross Margin QoQ = 31.84% (prev 33.29%)
Tobins Q-Ratio = 2.97 (Enterprise Value 6.84b / Total Assets 2.30b)
Interest Expense / Debt = 2.98% (Interest Expense 39.4m / Debt 1.32b)
Taxrate = 25.27% (79.7m / 315.4m)
NOPAT = 265.1m (EBIT 354.8m * (1 - 25.27%))
Current Ratio = 3.12 (Total Current Assets 1.19b / Total Current Liabilities 382.7m)
Debt / Equity = 1.90 (Debt 1.32b / totalStockholderEquity, last quarter 696.3m)
Debt / EBITDA = 1.82 (Net Debt 907.9m / EBITDA 498.1m)
Debt / FCF = 3.70 (Net Debt 907.9m / FCF TTM 245.2m)
Total Stockholder Equity = 678.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 10.83% (Net Income 235.7m / Total Assets 2.30b)
RoE = 34.75% (Net Income TTM 235.7m / Total Stockholder Equity 678.3m)
RoCE = 23.22% (EBIT 354.8m / Capital Employed (Equity 678.3m + L.T.Debt 850.0m))
RoIC = 14.36% (NOPAT 265.1m / Invested Capital 1.85b)
WACC = 8.16% (E(5.93b)/V(7.25b) * Re(9.49%) + D(1.32b)/V(7.25b) * Rd(2.98%) * (1-Tc(0.25)))
Discount Rate = 9.49% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -99.49 | Cagr: -2.90%
[DCF] Terminal Value 77.97% ; FCFF base≈168.3m ; Y1≈192.9m ; Y5≈283.9m
[DCF] Fair Price = 126.6 (EV 4.27b - Net Debt 907.9m = Equity 3.36b / Shares 26.6m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -2.33 | EPS CAGR: -0.06% | SUE: -0.48 | # QB: 0
Revenue Correlation: 88.08 | Revenue CAGR: 2.33% | SUE: 0.95 | # QB: 2
EPS current Quarter (2027-03-31): EPS=1.93 | Chg30d=-4.81% | Revisions=-67% | Analysts=10
EPS current Year (2026-12-31): EPS=10.30 | Chg30d=-1.32% | Revisions=-75% | GrowthEPS=-10.0% | GrowthRev=+0.6%
EPS next Year (2027-12-31): EPS=10.74 | Chg30d=-6.10% | Revisions=-79% | GrowthEPS=+4.3% | GrowthRev=+2.0%
[Analyst] Revisions Ratio: -90% (up=0, down=26)